Unlearn - About the company
Unlearn is a series C company based in San Francisco (United States), founded in 2017 by Charles Fisher. It operates as a Developer of an AI platform for clinical trial design and analysis. Unlearn has raised $135M in funding from investors like Insight Partners, EPIC Ventures and Altimeter Capital, with a current valuation of $*****. The company has 45 active competitors, including 15 that are funded. Its top competitors include companies like Virtonomy, Ryght and ELEM Biotech.
Company Details
Developer of an AI platform for clinical trial design and analysis. The platform provides tools for trial design, literature review, data exploration, and scenario building. It offers digital twins to forecast clinical trial participant outcomes. The platform aims to improve decision-making and efficiency in clinical development.
- Website
- www.unlearn.ai/
- Social
Key Metrics
Founded Year
2017
Location
San Francisco, United States
Stage
Series C
Total Funding
$135M in 6 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 01, 2026
Investors
Ranked
1st among 45 active competitors
Employee Count
74 as on Sep 30, 2026
Similar Companies
Sign up to download Unlearn's company profile
Unlearn's funding and investors
Unlearn has raised a total funding of $135M over 6 rounds. Its first funding round was on Jan 30, 2020. Its latest funding round was a Series C round on Jan 25, 2024 for $*****. 9 investors participated in its latest round. Unlearn has 15 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Unlearn:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 25, 2024 | 4297754 | Series C | 4158658 | 2142328 | 3078958 | 2097097 |
Mar 21, 2023 | 4278557 | Series B | 5392162 | 1410178 | 1635988 | 1204618 |
Apr 18, 2022 | 8310632 | Series B | 8740234 | 1133503 |
Access funding benchmarks and valuations. Sign up today!View details of Unlearn's funding rounds and investors
Unlearn's founders and board of directors
Founder? Claim ProfileThe founders of Unlearn is Charles Fisher. Steven Herne is the CEO of Unlearn.
Here are the details of Unlearn's key team members:
- Charles Fisher: Former Co-Founder of Unlearn and founder of 1 other company. They serve on the boards of 2 companies.
- Steven Herne: CEO of Unlearn. Contact Info: 1 email address
View details of Unlearn's Founder profiles and Board Members
Unlearn's employee count trend
Unlearn has 74 employees as of Sep 26. Here is Unlearn's employee count trend over the years:
Uncover Unlearn's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Unlearn's Competitors and alternates
Top competitors of Unlearn include Virtonomy, Ryght and ELEM Biotech. Here is the list of Top 10 competitors of Unlearn, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Unlearn 2017, San Francisco (United States), Series C | Developer of an AI platform for clinical trial design and analysis | $135M | 64/100 | |
2nd | Provider of virtual patient simulation for medical device development | $9.69M | 55/100 | ||
3rd |  Ryght 2023, Anaheim (United States), Series A | Generative AI platform focused on biopharma smart biomedical data | $7.25M | 54/100 | |
4th | ELEM Biotech 2018, Barcelona (Spain), Seed | Provider of a simulation based platform for doctors | $2.27M | 47/100 | |
5th | Provider of digital twin-based precision therapy solution | $2.78M | 41/100 | ||
6th |  Verto Health 2017, Toronto (Canada), Seed | Provider of AI-based digital twin platform for population health management | $1.52M | 39/100 | |
7th |  Adsilico 2022, London (United Kingdom), Seed | Provider of insilico trials using virtual patients to assess medical device safety | $4.56M | 38/100 | |
8th |  XY.ai 2017, Palo Alto (United States), Unfunded | Provides software for managing genetic and health data | - | - | 37/100 |
9th |  Precision Diagnosis Technology Series B | Provider of digital twin technology for precision medicine | $15.5M | 34/100 | |
10th | Provider of a blockchain technology based online platform for genomic data analytics | $3.37M | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Unlearn's competitors? Click here to see the top ones
Unlearn's Investments and acquisitions
Unlearn has made no investments or acquisitions yet.
Reports related to Unlearn
Here is the latest report on Unlearn's sector:
News related to Unlearn
Filter this listMedia has covered Unlearn for a total of 6 events in the last 1 year, 3 of them have been about partnerships and 2 about company updates.
•
Unlearn adds to Series A funding round, bringing the total to $15MMobiHealthNews•Aug 01, 2026•Unlearn
•
Acumen Pharmaceuticals and Unlearn Collaborate on Alzheimer's Disease Clinical Programs Using AINewswire•Jul 09, 2026•Acumen Pharmaceuticals, Unlearn
•
Unlearn to Support SOLA Biosciences' Clinical Study Using AI-Generated Digital TwinsNewswire•Mar 10, 2026•SOLA Biosciences, Unlearn
•
Unlearn Advances Huntington's Disease AI Modeling via CHDI Foundation DataNewswire•Feb 24, 2026•Chdifoundation, Unlearn
•
Unlearn Partners with VectorY Therapeutics on ALS Clinical StudyNewswire•Feb 12, 2026•Vectory Sensor Systems, Unlearn
•
Unlearn Introduces TrialPioneer, AI-powered Workspace for Upstream Trial PlanningNewswire•Jan 28, 2026•Unlearn
•
•
•
Abridge Secures $300M for AI Medical Note-Taking TechnologyPYMNTS.com•Jun 24, 2025•Abridge Inc, Unlearn
•
Unlearn and remynd Partner on Alzheimer’s Study to Strengthen Confidence in Early Clinical Signals Using Digital TwinsBusiness Wire•Apr 03, 2025•reMYND, Unlearn
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Unlearn
Explore our recently published companies
- Study Knowledge - India based, Unfunded company
- Digitales Lernen Berlin - Germany based, Unfunded company
- MedNavi AI - Unfunded company
- Daar Market Intelligence - United Arab Emirates based, 2025 founded, Unfunded company
- Re-Motion Home - Germany based, Unfunded company
- ToDo Auto Repair - Leduc based, Unfunded company
